Wonbiogen Co., Ltd. (KOSDAQ:307280)
South Korea · Delayed Price · Currency is KRW 7,220.00
-160.00 (-2.17%)
At close: Apr 24, 2026
Wonbiogen Revenue
In the year 2025, Wonbiogen had annual revenue of 35.24B KRW with 15.78% growth. Wonbiogen had revenue of 9.37B in the quarter ending December 31, 2025, with 10.15% growth.
Revenue
35.24B
Revenue Growth
+15.78%
P/S Ratio
1.45
Revenue / Employee
n/a
Employees
n/a
Market Cap
51.21B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 35.24B | 4.80B | 15.78% |
| Dec 31, 2024 | 30.44B | 824.93M | 2.79% |
| Dec 31, 2023 | 29.61B | 2.87B | 10.72% |
| Dec 31, 2022 | 26.75B | 9.03B | 50.94% |
| Dec 31, 2021 | 17.72B | 5.70B | 47.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| KM Corporation | 135.41B |
| JW Shinyak | 81.04B |
| Sewoon Medical | 63.66B |
| CG MedTech | 47.23B |
| OSTEONIC | 45.39B |
| DuChemBIO | 38.57B |
| Billions | 25.31B |
| SCL Science | 22.01B |